Skip to main content

Passive Immune Protection from Diarrhea Caused by Rotavirus or E. Coli: An Animal Model to Demonstrate and Quantitate Efficacy

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 310))

Abstract

Several studies have described the use of orally administered passive antibodies from heterologous species origin to control enteric disease caused by bacteria1–4, viruses5–13, and protozoa14. Both the therapeutic and prophylactic properties of passive antibodies have been evaluated. The therapeutic efficacy has been confined to suppressed pathogen shedding with limited effects reported on the acute clinical disease2,12. The reported lack of therapeutic effect on the course of the Escherichia coli and rotavirus diarrhea episodes may be attributed to the self-limiting nature of these diarrheas in healthy patients. Passive antibody is effective in treating Cryptosporidium infection14 and may also be effective in treating chronic diarrhea in immunocompromised patients.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. D. Rivier and J. Sabotka, Exp. Cell Biol. 46: 277 (1978).

    PubMed  CAS  Google Scholar 

  2. C. Mietens, H. Keinhorst, H. Hilpert, H. Gerber, H. Amster, and J. Pahud, Eur. J. Pediatr. 132: 239 (1979).

    Article  PubMed  CAS  Google Scholar 

  3. M. Linggood, P. Porter, and J. Powell, European Patent Application Number 83305051.1, publication number 0102831 (1984).

    Google Scholar 

  4. C. Tacket, G. Losonsky, H. Link, Y. Hoang, P. Guesry, H. Hilpert, and M. Levine, N. Engl. J. Med. 318: 1240 (1988).

    Article  PubMed  CAS  Google Scholar 

  5. D. Snodgrass and P. Wells, Arch. Virol. 52: 201 (1976).

    Article  PubMed  CAS  Google Scholar 

  6. C. Bartz, R. Conklin, C. Tunstall, and J. Steele, J. Infect. Dis. 142: 439 (1980).

    Article  PubMed  CAS  Google Scholar 

  7. J. Bridger and J. Brown, Infect. Immun. 31: 906 (1981).

    PubMed  CAS  Google Scholar 

  8. L. Saif, D. Redman, K. Smith, and K. Theirl, Infect. Immun. 41: 1118 (1983).

    PubMed  CAS  Google Scholar 

  9. J. Sheridan, C. Smith, M. Manak, and L. Aurlian, J. Infec. Dis. 149: 434 (1984).

    Article  CAS  Google Scholar 

  10. P. Offit and H. Clark, J. Virol. 54: 58 (1985).

    PubMed  CAS  Google Scholar 

  11. T. Ebina, A. Sato, K. Umezu, N. Ishida, S. Ohyama, A. Ahizumi, K. Aikawa, S. Katagiri, N. Katsushima, A. Imai, S. Kitaoka, H. Suzuki, and T. Konno, Med. Microbiol. Immunol. 174: 177 (1985).

    Article  PubMed  CAS  Google Scholar 

  12. H. Hilpert, H. Brussow, C. Mietens, J. Sidoti, L. Lerner, and H. Werchau, J. Infec. Dis. 156: 158 (1987).

    Article  CAS  Google Scholar 

  13. G. Davidson, E. Daniels, H. Nunan, A. Moore, P. Whyte, K. Franklin, P. McCloud, and D. Moore, Lancet Sept. 23: 709 (1989).

    Article  Google Scholar 

  14. S. Tzipori, D. Robertson, and C. Chapman, Brit. Med. J. 293: 1276 (1986).

    Article  CAS  Google Scholar 

  15. A. Kapikian, H. Kim, R. Wyatt, W. Cline, J. Arrobio, C. Brandt, W. Rodriquez, D. Sack, R. Chanock, and R. Parrott, N. Engl. J. Med. 294: 965 (1976).

    Article  PubMed  CAS  Google Scholar 

  16. S. Gorbach, B. Kean, D. G. Evans, D. J. Evans, and D. Bessudo, N. Engl. J. Med. 292: 933 (1975).

    Article  PubMed  CAS  Google Scholar 

  17. R. Black, Rev. Infect. Dis. 8: S131 (1986).

    Article  PubMed  Google Scholar 

  18. D. Taylor and P. Echeverria, Rev. Infect. Dis. 8: S136 (1986).

    Article  PubMed  Google Scholar 

  19. R. C. Meyer, E. H. Bohl, and E. M. Kahler, Appl. Microbial. 2: 295 (1964).

    Google Scholar 

  20. R. Wyatt, W. James, E. Bohl, K. Theil, L. Saif, A. Kapikian, and R. Chanock, Science 207: 189 (1980).

    Article  PubMed  CAS  Google Scholar 

  21. S. Urasawa, T. Urasawa, and K. Taniguchi, Infect. Immun. 38: 781 (1982).

    PubMed  CAS  Google Scholar 

  22. A. Torres and L. Ji-Huang, J. Virol. 60: 1107 (1986).

    PubMed  CAS  Google Scholar 

  23. H. Malherbe and M. Strictland-Chomley, Arch. Gesamt. Virusforsch. 22: 235 (1967).

    Article  CAS  Google Scholar 

  24. M. M. Levine, J. B. Kaper, R. E. Black, and M. L. Clements, Micro. Rev. 47: 510 (1983).

    CAS  Google Scholar 

  25. L. J. Saif, K. L. Smith, B. J. Landmeier, E. H. Bohl, K. W. Theil, and D. A. Todhunter, Amer. J. Vet. Res. 45: 49 (1984).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Cordle, C.T. et al. (1991). Passive Immune Protection from Diarrhea Caused by Rotavirus or E. Coli: An Animal Model to Demonstrate and Quantitate Efficacy. In: Mestecky, J., Blair, C., Ogra, P.L. (eds) Immunology of Milk and the Neonate. Advances in Experimental Medicine and Biology, vol 310. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3838-7_41

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3838-7_41

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6713-0

  • Online ISBN: 978-1-4615-3838-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics